Portal Therapeutics, Inc.
3 clinical trials · Sponsor
◉ Watch Portal Therapeutics, Inc.
| Record | Firm | Date |
|---|---|---|
| Observational Study of Adults and Adolescents With Erythropoietic Protoporphyria (EPP) and X-linked Porphyria (XLP) (NCT07567131) | Portal Therapeutics, Inc. | 2026-04-30 |
| GATEWAY: A Phase 2a Study of PORT-77 in Adults With Erythropoietic Protoporphyria (NCT06971900) | Portal Therapeutics, Inc. | 2025-04-04 |
| Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study of PORT-77 Administered to Healthy Adult Participants (NCT06346509) | Portal Therapeutics, Inc. | 2024-04-08 |
Track Portal Therapeutics, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.